Xinfamousxi
New Member
I'm glad I found this site and have read a bunch. I have symptoms of low T and visited a male clinic that wants me to get on on 140mg of test once a week along with an AI and Clomid. After what I read here I'm going to push back on the Clomid and AI and only accept the test. I'm also going to ask for twice a week injections. My questions are as follows
1. Do you see anything on my pre treatment labs I should look into before starting TRT?
2. When I asked about HCG they said they can provide me info of where to get it. Not sure what that means, but not worried about it now as I will not be having more kids.
A little about me. I'm a 5'9 36 year old male that weighted about 218 at the start of this year currently 183lbs . I started lifting 3 times a week. 10k + steps a day and eating mainly whole foods. I cut out all the sugary drinks and only drink water at least a gallon a day. The thought of injections is scaring me, but I hope to get use to it and then just start injecting myself along with the HCG.
Symptoms:
Low Libido
Sleeping issues (cant sleep through the night)
ED
Starting to stale and can gain muscle
Dr recently prescribes Cialis and it has helped tremendously the ED which I think naturally improved the libido. I also do use a CPAP for the last 4 years. Just had a sleep study and they lowered the pressure from 14 to 7 due to the weight loss.
F | GLUCOSE | 95 | 65-99 (mg/dL) | KS |
- | ||||
- Fasting reference interval | ||||
- | ||||
F | UREA NITROGEN (BUN) | 18 | 7-25 (mg/dL) | KS |
F | CREATININE | 1.04 | 0.60-1.26 (mg/dL) | KS |
F | EGFR | 95 | > OR = 60 (mL/min/1.73m2) | KS |
- The eGFR is based on the CKD-EPI 2021 equation. To calculate | ||||
- the new eGFR from a previous Creatinine or Cystatin C | ||||
- result, go to Kidney Professionals | ||||
- kdoqi/gfr%5Fcalculator | ||||
F | BUN/CREATININE RATIO | NOT APPLICABLE | 6-22 ((calc)) | KS |
F | SODIUM | 139 | 135-146 (mmol/L) | KS |
F | POTASSIUM | 4.7 | 3.5-5.3 (mmol/L) | KS |
F | CHLORIDE | 103 | 98-110 (mmol/L) | KS |
F | CARBON DIOXIDE | 29 | 20-32 (mmol/L) | KS |
F | CALCIUM | 9.7 | 8.6-10.3 (mg/dL) | KS |
F | PROTEIN, TOTAL | 7.3 | 6.1-8.1 (g/dL) | KS |
F | ALBUMIN | 4.9 | 3.6-5.1 (g/dL) | KS |
F | GLOBULIN | 2.4 | 1.9-3.7 (g/dL (calc)) | KS |
F | ALBUMIN/GLOBULIN RATIO | 2.0 | 1.0-2.5 ((calc)) | KS |
F | BILIRUBIN, TOTAL | 1.0 | 0.2-1.2 (mg/dL) | KS |
F | ALKALINE PHOSPHATASE | 77 | 36-130 (U/L) | KS |
F | AST | 20 | 10-40 (U/L) | KS |
F | ALT | 19 | 9-46 (U/L) | KS |
F | WHITE BLOOD CELL COUNT | 4.6 | 3.8-10.8 (Thousand/uL) | KS |
F | RED BLOOD CELL COUNT | 5.41 | 4.20-5.80 (Million/uL) | KS |
F | HEMOGLOBIN | 16.2 | 13.2-17.1 (g/dL) | KS |
F | HEMATOCRIT | 47.8 | 38.5-50.0 (%) | KS |
F | MCV | 88.4 | 80.0-100.0 (fL) | KS |
F | MCH | 29.9 | 27.0-33.0 (pg) | KS |
F | MCHC | 33.9 | 32.0-36.0 (g/dL) | KS |
F | RDW | 13.3 | 11.0-15.0 (%) | KS |
F | PLATELET COUNT | 220 | 140-400 (Thousand/uL) | KS |
F | MPV | 9.9 | 7.5-12.5 (fL) | KS |
F | ABSOLUTE NEUTROPHILS | 2479 | 1500-7800 (cells/uL) | KS |
F | ABSOLUTE LYMPHOCYTES | 1628 | 850-3900 (cells/uL) | KS |
F | ABSOLUTE MONOCYTES | 313 | 200-950 (cells/uL) | KS |
F | ABSOLUTE EOSINOPHILS | 161 | 15-500 (cells/uL) | KS |
F | ABSOLUTE BASOPHILS | 18 | 0-200 (cells/uL) | KS |
F | NEUTROPHILS | 53.9 | (%) | KS |
F | LYMPHOCYTES | 35.4 | (%) | KS |
F | MONOCYTES | 6.8 | (%) | KS |
F | EOSINOPHILS | 3.5 | (%) | KS |
F | BASOPHILS | 0.4 | (%) | KS |
F | DHEA SULFATE | 363 | 93-415 (mcg/dL) | KS |
F | FSH | 2.1 | 1.6-8.0 (mIU/mL) | KS |
F | LH | 3.3 | 1.5-9.3 (mIU/mL) | KS |
F | T4, FREE | 1.3 | 0.8-1.8 (ng/dL) | KS |
F | TESTOSTERONE, TOTAL, MALES (ADULT), IA | 325 | 250-827 (ng/dL) | KS |
F | TSH | 2.41 | 0.40-4.50 (mIU/L) | KS |
F | ESTRADIOL | 21 | < OR = 39 (pg/mL) | KS |
- Reference range established on post-pubertal patient | ||||
- population. No pre-pubertal reference range | ||||
- established using this assay. For any patients for | ||||
- whom low Estradiol levels are anticipated (e.g. males, | ||||
- pre-pubertal children and hypogonadal/post-menopausal | ||||
- females), the Quest Diagnostics Nichols Institute | ||||
- Estradiol, Ultrasensitive, LCMSMS assay is recommended | ||||
- (order code 30289). | ||||
- | ||||
- Please note: patients being treated with the drug | ||||
- fulvestrant (Faslodex(R)) have demonstrated significant | ||||
- interference in immunoassay methods for estradiol | ||||
- measurement. The cross reactivity could lead to falsely | ||||
- elevated estradiol test results leading to an | ||||
- inappropriate clinical assessment of estrogen status. | ||||
- Quest Diagnostics order code 30289-Estradiol, | ||||
- Ultrasensitive LC/MS/MS demonstrates negligible cross | ||||
- reactivity with fulvestrant. | ||||
F | PSA, TOTAL | 0.42 | < OR = 4.00 (ng/mL) | KS |
- The total PSA value from this assay system is | ||||
- standardized against the WHO standard. The test | ||||
- result will be approximately 20% lower when compared | ||||
- to the equimolar-standardized total PSA (Beckman | ||||
- Coulter). Comparison of serial PSA results should be | ||||
- interpreted with this fact in mind. | ||||
- | ||||
- This test was performed using the Siemens | ||||
- chemiluminescent method. Values obtained from | ||||
- different assay methods cannot be used | ||||
- interchangeably. PSA levels, regardless of | ||||
- value, should not be interpreted as absolute | ||||
- evidence of the presence or absence of disease. | ||||
F | SEX HORMONE BINDING GLOBULIN | 24 | 10-50 (nmol/L) | KS |
F | T3, FREE | 3.4 | 2.3-4.2 (pg/mL) | KS |